<?xml version="1.0" encoding="UTF-8"?>
<p>Mechanistically, it has been suggested that LA may partially inhibit the enzyme PCSK9, which regulates the hepatic LDL receptorâ€™s degradation, in a manner similar to (albeit much less effective than) that of currently available drugs, i.e., alirocumab and evolocumab. This hypothesis, however, requires further confirmation. Further, plasma levels of linoleic acid positively correlate with insulin sensitivity [
 <xref rid="B71-nutrients-12-03782" ref-type="bibr">71</xref>]. The net result of using recommended amounts of omega 6 fatty acids is that of cardiovascular risk reduction. Aside from epidemiological studies, one arm of the clinical trial PREDIMED, i.e., the one where patients were given linoleic acid-rich dried fruit and nuts, confirmed cardiovascular protection [
 <xref rid="B74-nutrients-12-03782" ref-type="bibr">74</xref>].
</p>
